Immunology

  1. Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors

    1. Josée Perreault
    2. Tony Tremblay
    3. Marie-Josée Fournier
    4. Mathieu Drouin
    5. Guillaume Beaudoin-Bussières
    6. Jérémie Prévost
    7. Antoine Lewin
    8. Philippe Bégin
    9. Andrés Finzi
    10. Renée Bazin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination

    1. Shang Jui Tsai
    2. Chenxu Guo
    3. Alanna Sedgwick
    4. Saravana Kanagavelu
    5. Justin Nice
    6. Sanjana Shetty
    7. Connie Landaverde
    8. Nadia A. Atai
    9. Stephen J. Gould

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes

    1. Edwards Pradenas
    2. Benjamin Trinité
    3. Víctor Urrea
    4. Silvia Marfil
    5. Carlos Ávila-Nieto
    6. María Luisa Rodríguez de la Concepción
    7. Ferran Tarrés-Freixas
    8. Silvia Pérez-Yanes
    9. Carla Rovirosa
    10. Erola Ainsua-Enrich
    11. Jordi Rodon
    12. Júlia Vergara-Alert
    13. Joaquim Segalés
    14. Victor Guallar
    15. Alfonso Valencia
    16. Nuria Izquierdo-Useros
    17. Roger Paredes
    18. Lourdes Mateu
    19. Anna Chamorro
    20. Marta Massanella
    21. Jorge Carrillo
    22. Bonaventura Clotet
    23. Julià Blanco

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics

    1. Rohan Sivapalan
    2. Jinyan Liu
    3. Krishnendu Chakraborty
    4. Elisa Arthofer
    5. Modassir Choudhry
    6. Philip S. Barie
    7. Dan H. Barouch
    8. Tom Henley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques

    1. Timothy N. Hoang
    2. Maria Pino
    3. Arun K. Boddapati
    4. Elise G. Viox
    5. Carly E. Starke
    6. Amit A. Upadhyay
    7. Sanjeev Gumber
    8. Michael Nekorchuk
    9. Kathleen Busman-Sahay
    10. Zachary Strongin
    11. Justin L. Harper
    12. Gregory K. Tharp
    13. Kathryn L. Pellegrini
    14. Shannon Kirejczyk
    15. Keivan Zandi
    16. Sijia Tao
    17. Tristan R. Horton
    18. Elizabeth N. Beagle
    19. Ernestine A. Mahar
    20. Michelle Y.H. Lee
    21. Joyce Cohen
    22. Sherrie M. Jean
    23. Jennifer S. Wood
    24. Fawn Connor-Stroud
    25. Rachelle L. Stammen
    26. Olivia M. Delmas
    27. Shelly Wang
    28. Kimberly A. Cooney
    29. Michael N. Sayegh
    30. Lanfang Wang
    31. Peter D. Filev
    32. Daniela Weiskopf
    33. Guido Silvestri
    34. Jesse Waggoner
    35. Anne Piantadosi
    36. Sudhir P. Kasturi
    37. Hilmi Al-Shakhshir
    38. Susan P. Ribeiro
    39. Rafick P. Sekaly
    40. Rebecca D. Levit
    41. Jacob D. Estes
    42. Thomas H. Vanderford
    43. Raymond F. Schinazi
    44. Steven E. Bosinger
    45. Mirko Paiardini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection

    1. Anne C. Moore
    2. Emery G. Dora
    3. Nadine Peinovich
    4. Kiersten P. Tucker
    5. Karen Lin
    6. Mario Cortese
    7. Sean N. Tucker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

    1. Emma S. Winkler
    2. Pavlo Gilchuk
    3. Jinsheng Yu
    4. Adam L. Bailey
    5. Rita E. Chen
    6. Zhenlu Chong
    7. Seth J. Zost
    8. Hyesun Jang
    9. Ying Huang
    10. James D. Allen
    11. James Brett Case
    12. Rachel E. Sutton
    13. Robert H. Carnahan
    14. Tamarand L. Darling
    15. Adrianus C.M. Boon
    16. Matthias Mack
    17. Richard D. Head
    18. Ted M. Ross
    19. James E. Crowe
    20. Michael S. Diamond

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates

    1. Dapeng Li
    2. Robert J Edwards
    3. Kartik Manne
    4. David R. Martinez
    5. Alexandra Schäfer
    6. S. Munir Alam
    7. Kevin Wiehe
    8. Xiaozhi Lu
    9. Robert Parks
    10. Laura L. Sutherland
    11. Thomas H. Oguin
    12. Charlene McDanal
    13. Lautaro G. Perez
    14. Katayoun Mansouri
    15. Sophie M. C. Gobeil
    16. Katarzyna Janowska
    17. Victoria Stalls
    18. Megan Kopp
    19. Fangping Cai
    20. Esther Lee
    21. Andrew Foulger
    22. Giovanna E. Hernandez
    23. Aja Sanzone
    24. Kedamawit Tilahun
    25. Chuancang Jiang
    26. Longping V. Tse
    27. Kevin W. Bock
    28. Mahnaz Minai
    29. Bianca M. Nagata
    30. Kenneth Cronin
    31. Victoria Gee-Lai
    32. Margaret Deyton
    33. Maggie Barr
    34. Tarra Von Holle
    35. Andrew N. Macintyre
    36. Erica Stover
    37. Jared Feldman
    38. Blake M. Hauser
    39. Timothy M. Caradonna
    40. Trevor D. Scobey
    41. Wes Rountree
    42. Yunfei Wang
    43. M. Anthony Moody
    44. Derek W. Cain
    45. C. Todd DeMarco
    46. ThomasN. Denny
    47. Christopher W. Woods
    48. Elizabeth W. Petzold
    49. Aaron G. Schmidt
    50. I-Ting Teng
    51. Tongqing Zhou
    52. Peter D. Kwong
    53. John R. Mascola
    54. Barney S. Graham
    55. Ian N. Moore
    56. Robert Seder
    57. Hanne Andersen
    58. Mark G. Lewis
    59. David C. Montefiori
    60. Gregory D. Sempowski
    61. Ralph S. Baric
    62. Priyamvada Acharya
    63. Barton F. Haynes
    64. Kevin O. Saunders

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Ubiquitin ligase RIPLET mediates polyubiquitination of RIG-I and LGP2 and regulates the innate immune responses to SARS-CoV-2 infection

    1. Takahisa Kouwaki
    2. Tasuku Nishimura
    3. Guanming Wang
    4. Reiko Nakagawa
    5. Hiroyuki Oshiumi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

    1. Jeroen Pollet
    2. Wen-Hsiang Chen
    3. Leroy Versteeg
    4. Brian Keegan
    5. Bin Zhan
    6. Junfei Wei
    7. Zhuyun Liu
    8. Jungsoon Lee
    9. Rahki Kundu
    10. Rakesh Adhikari
    11. Cristina Poveda
    12. Maria Jose Villar
    13. Ana Carolina de Araujo Leao
    14. Joanne Altieri Rivera
    15. Zoha Momin
    16. Portia M. Gillespie
    17. Jason T. Kimata
    18. Ulrich Strych
    19. Peter J. Hotez
    20. Maria Elena Bottazzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 129 of 175 Next